1.STUDY ON THE EFFECT OF DIFFERENT DIETARY FATTY ACID COMPOSITIONS ON MNU-INDUCED BREAST TUMORS IN RATS
Na WEI ; Mantian MI ; Bin WANG
Acta Nutrimenta Sinica 1956;0(03):-
Objective: To study the effect of different dietary fatty acid compositions on breast tumors induced by methyl-nitrosourea(MNU) in rats. Method: Female SD rats were fed diets containing 15% fat (wt/wt) in the experimental period. At age of 50d, rats were randomly assigned to 8 groups and each group was suldivided into tumor group and control group. The tumor group was given a single ip injection of MNU (50 mg/kg bw) and switched to one of 8 different diets containing following fatty acids: saturated fatty acid(SFA); monounsaturated fatty acid(MUFA); n-6 polyunsaturated fatty acid(PUFA); n-3 PUFA; 1∶1 n-6/n-3; 5∶1 n-6/n-3; 10∶1 n-6/n-3; 1∶2∶1 S/M/P(n-6/n-3 at 1∶1) for 18w. The control groups received the physiological saline only. The weight growth, mammary tumor incidence, tumor multiplicity, and tumor latency were observed. Results: Except the weight growth was arrested in rats fed on n-3 PUFA 6w later, there was no significant difference in weight growth among the other groups. Additionally, there was no mammary tumor occurrence in control groups, but in model groups, the incidence of mammary tumors in rats fed on SFA, MUFA, n-6 PUFA,5∶1 n-6/n-3, 10∶1 n-6/n-3 and 1∶2∶1 S/M/P diets was twice higher than that in rats fed on 1∶1 n-6/n-3 diet, although there was also no tumorin rats fed on n-3 PUFA diet. Moreover, tumor multiplicity in rats fed on 1∶1 n-6/n-3 diet was obviously decreased in comparison with those groups, and tumor latency was prolonged too. Conclusion: The different dietary fatty acid compositions can diversely influence MNU-induced breast tumors incidence in rats and 1∶1 n-6/n-3 has obvious inhibitory effect.
2.Hyperuricaemia and blood pressure, and blood lipid and glucose
Ai ZHAO ; Bofei SHI ; Yuan HE ; Jun DIE ; Hai MI ; Na WANG ; Aiping LIU ; Peiyu WANG
Chinese Journal of Health Management 2011;05(2):87-90
Objective To explore the correlation between hyperuricaemia and blood pressure, and blood lipid and glucose. Methods By using simple cluster sampling, 2 branch units from PetroChina Changqing Oilfield Company were selected, and all the 720 subjects with hyperuricaemia (HUA) were assigned to the HUA group; another 620 participants with normal uric acid (UA) level into the normal group. The correlation between blood uric acid and blood pressure,and blood lipid and glucose was assessed by Logistic regression. Results The odds ratio (OR) of those who had 1,2 or 3 abnormal status of hypertension,hyperlipidemia and impaired fasting glucose in the HUA group were much higher than the normal group (OR values were 4. 036,2. 562, and 4. 174, respectively). Logistic regression showed that male, systolic blood pressure ( SBP), GLU, total cholesterol ( TC), triglyceride ( TG), low-density lipoprotein cholesterol (LDL-C) were risk factors of H UA ( OR values were 7. 736,2. 309,1.721,2. 761 and 1. 411,respectively) ,while high-density lipoprotein cholesterol (HDL-C, OR = 0. 211 ) was a protective factor of HUA. Conclusions Gender,blood pressure and blood lipid may have correlation with blood UA. Multiple risk factors should be considered to improve the effectiveness of health education and health promotion.
3.The relation of early time secretion function of Beta cell in newly diagnosed type 2 diabetic patient and body weight changes following intensification therapy of insulin
Lixin YANG ; Yaping ZHANG ; Na MI ; Ye WANG ; Qinfang ZHU ; Weiliang HAN ; Yinjuan LI
Clinical Medicine of China 2009;25(10):1061-1063
Objective To explore the relation of early time secretion function of Beta cell in newly diag-nosed type 2 diabetic patient and the changes of body weight following intensification therapy of insulin. Methods 237 newly diagnosed type 2 diabetic patients were divided into 1 kg lower group, the 1-5 kg group, the 5 kg above group. The maximum body weight and waist circumference were recorded. The present body weight and waist circum-ference were measured according to OGTT study, meanwhile,30 minuets blood sugars, the insulin and the C-peptide (C-P) level and the blood pressure(BP) and the insulin resistance index (HOMA-IR), the early insulin secretion index (△I30/△G30) was calculated. All cases were treated for 14 days. Results Early time secretion function of Beta cell in the group keeping above lose weight 5 kg was the worst, after treatment insulin secretion level were in-creased 1.12 times and 1.86 times in 1 kg lower group than in the 1-5 kg group and above 5 kg group. Conclusions Early time secretion function of Beta cell in newly diagnosed type 2 diabetic patient is correlated with the maxi-mum body weight decrease.
4.Preventive Measures and Stepwise Treatment of Fungal Urinary Tract Infection Based on TCM Syndrome Differentiation
Min YU ; Bing HAN ; Yaoxun SHI ; Mi TIAN ; Anna WANG ; Zhen ZENG ; Na WEN
Chinese Journal of Nosocomiology 2004;0(10):-
OBJECTIVE To discuss the clinical traits,pathogenesis and TCM stepwise treatments of fungal urinary tract infection.METHODS According to the risk factors and clinical character of fungal urinary tract infection,we clarified the mechanism of the disease.The principal aspect was spleen-kidney vacuity detriment and the secondary incidental was accumulated damp-heat and static blood in the lower burner,viz weaken healthy qi and excessive pathogenic factor.Hence during the clinical treatment we should regulate faculty condition.In the acute infection period we should give priority to dispel evils supplemented by the recovery of right qi.In the convalescence we should pay more attention to support right supplemented by dispelling.RESULTS The most common pathogen of fungal urinary tract infection was Candida albicans.The TCM stepwise treatments of fungal urinary tract infection together with regulatiy entire faculty condition had the characteristics of high efficacy and few side effects.CONCLUSIONS The TCM stepwise treatments of fungal urinary tract infection has more potentiality which deserves further study.
5.Glycated hemoglobin levels in non-diabetic adults residing at different altitudes and influencing factors
Lixin YANG ; Na MI ; Ye WANG ; Qinfang ZHU ; Weiliang HAN ; Jinjuan LI ; Shu LI ; Peng CHEN ; Zhong HE
Chinese Journal of Endocrinology and Metabolism 2012;28(5):412-413
In the present study,healthy adults who had been residing at the average altitudes of 6,2260,and 2800 m for 10 years were recruited,and the number of red blood cells,the levels of hemoglobin,and HbA1C were tested.The results showed that the level of HbA1C in altitude 2800 m group was higher compared with the other 2 groups(5.80% ± 0.50% vs 5.39% ± 0.47%,P<0.05 ).Therefore,this difference should be considered when diagnosis and treatment for diabetes mellitus were made in the region.
6.Safety of metformin in diabetic patients at high altitude area
Lixin YANG ; Na MI ; Ye WANG ; Qinfang ZHU ; Weiliang HAN ; Jinjuan LI ; Shu LI ; Peng CHEN ; Zhong HE
Chinese Journal of Endocrinology and Metabolism 2010;26(10):865-867
Sixty-one newly-diagnosed diabetic patients from high altitude area were treated individually plus metformin 1.5 g/d for 14 days. The difference of oxygen partial pressure was 3.5 mm Hg (1 mm Hg=0. 133kPa) between altitude 2 260 m and 2 780 m districts. In these patients, their serum lactic acid was increased before treatment. At altitude 2 780 m district, serum lactic acid in middle-aged and elder groups were even higher [(3.90±0.85 vs 3.65±0.70), (4. 67±0.80 vs 3.69±0.78) mmol/L, both P<0. 05=. After 14-day treatment, serum lactic acid in middle-aged diabetic patients remained statistically unchanged [(4.50±0.50 and 3.79±0.62 ) mmol/L, P>0.05], while that in elder patients was increased significantly [(5.59±0.55 and 5.27±0.43 ) mmol/L,P<0. 05]. The results suggested that metformin should not be used or be used carefully in elder diabetic patients at high altitude area.
7.Synthesis and protective effect of ligustrazine intermediates against CoCl2-induced neurotoxicity in differentiated PC12 cell.
Guo-Liang LI ; Peng-Long WANG ; Xin XU ; Jin-Xuan LIN ; Fu-Hao CHU ; Ji-Xiang SONG ; Shen ZHOU ; Mi-Na WANG ; Yu-Zhong ZHANG ; Hai-Min LEI
China Journal of Chinese Materia Medica 2014;39(14):2679-2683
Ligustrazine, one of the major effective components of the Chinese traditional medicinal herb Ligusticum Chuanxiong Hort, has been reported plenty of biological activities, such as protect cardiovascular and cerebrovascular, neuroprotection and anti-tumor, et al. Because of its remarkable effects, studies on structural modification of ligustrazine have attracted much attention. Ligustrazine synthetic derivatives reported in recent decades are mainly derived from four primary intermediates (TMP-COOH, TMP-OH, TMP-NH2, HO-TMP-OH). To explore the neuroprotection activitiy of ligustrazine intermediates, six ligustrazine intermediates (2, 5, 8, 11, 12, 13) were synthesized and their protective effects against CoCl2-induced neurotoxicity in differentiated PC12 cells were studied. The target compounds were prepared via different chemical methods, including oxidation, substitution, esterification and amidation without changing the structure nucleus of ligustrazine. Compared with TMP (EC50 = 56.03 micromol x L(-1)), four compounds (2, 5, 12 and 13) exhibited higher activity (EC50 < 50 micromol x L(-1)) respectively, of which, compound 2 displayed the highest protective effect against the damaged PC12 cells (EC50 = 32.86 micromol x L(-1)), but target compounds 8 and 11 appeared lower activity (EC50 > 70 micromol x L(-1)). By structure-activity relationships analysis, the introduction of carboxyl, amino to the side chain of ligustrazine and appropriately increase the proportion of ligustrazine may contribute to enhance its neuroprotective activity, which provides a reference for the design, synthesis and activity screening of relevant series of ligustrazine derivatives in the future.
Animals
;
Cell Differentiation
;
drug effects
;
Chemistry Techniques, Synthetic
;
Cobalt
;
toxicity
;
Drugs, Chinese Herbal
;
chemistry
;
Neuroprotective Agents
;
chemical synthesis
;
chemistry
;
pharmacology
;
Neurotoxins
;
toxicity
;
PC12 Cells
;
Pyrazines
;
chemical synthesis
;
chemistry
;
pharmacology
;
Rats
9.Expression of Apollon and Caspase 9 in gastric carcinoma and their relationship
Mi-Na WANG ; Fan WANG ; Chun-Mei YAO ; Hong HUI
Chinese Journal of Clinical and Experimental Pathology 2019;35(2):169-172
Purpose To explore the expression,significance and relationship of apoptosis related gene Apollon and Caspase 9 in gastric carcinoma. Methods The SP immunohistochemical method was used to detect the expression of Apollon and Caspase 9 in 105 cases of gastric carcinoma,38 adjacent tissues and 29 normal tissues,and the expression of Apollon and Caspase 9 was analyzed with relation to clinicopathologic factors. Results The numbers of positive expression of Apollon gene in gastric carcinoma tissues,adjacent tissues and normal tissues were 82(78. 10%) ,8(21. 05%) and 2(6. 90%) respectively, there was significant difference between gastric carcinoma tissues, adjacent tissues and normal tissues (P < 0. 01) . The expression of Apollon in gastric carcinoma was positively correlated with degree of tumor differentiation,TNM staging and lymph node metastasis (P < 0. 05) ,but not with other clinicopathologic factors (P > 0. 05) . The numbers of positive expression of Caspase 9 gene in gastric carcinoma tissues,adjacent tissues and normal tissues were 21 (20. 00%) ,23 (60. 53%) and 21 (72. 41%) ,respectively,and there was significant difference between gastric carcinoma tissues,adjacent tissues and normal tissues (P < 0. 01) . The expression of Caspase 9 in gastric carcinoma was positively correlated with degree of tumor differentiation, TNM staging and lymph node metastasis (P < 0. 01) ,but not with other clinicopathologic factors (P > 0. 05) . The expression of Apollon was negatively correlated to Caspase 9 in gastric carcinoma with statistical significance (r = - 0. 541 1,P < 0. 01) . Conclusions The interaction of Apollon and Caspase 9 may be involved in the gastric carcinogenesis and progression. Apollon is closely related with invasion and metastasis of gastric carcinoma,and it may be a potential treatment target.
10.Effect of Astragali Radix in improving early renal damage in metabolic syndrome rats through ACE2/Mas pathway.
Qiong-ying WANG ; Wei LIANG ; Cheng JIANG ; Ning-yin LI ; Han XU ; Mi-na YANG ; Xin LIN ; Heng YU ; Peng CHANG ; Jing YU
China Journal of Chinese Materia Medica 2015;40(21):4245-4250
To study the expression of angiotensin converting enzyme 2 (ACE2) and angiotensin (Ang) 1-7 specific receptor Mas protain in renal blood vessels of metabolic syndrome ( MS) rats and its anti-oxidative effect. A total of 80 male SD rats were divided into four groups: the normal control group (NC, the same volume of normal saline), the MS group (high fat diet), the MS + Astragali Radix group (MS + HQ, 6 g x kg(-1) x d(-1) in gavage) and the MS + Valsartan group (MS + XST, 30 mg x kg(-1) x d(-1) in gavage). After four weeks of intervention, their general indexes, biochemical indexes and blood pressure were measured; plasma and renal tissue Ang II, malondialdehyde (MDA) and superoxide demutase (SOD) levels were measured with radioimmunoassay. The protein expressions of Mas receptor, AT1R, ACE and ACE2 were detected by western blot analysis. According to the result, compared with the NC group, the MS group and the MS + HQ group showed significant increases in systolic and diastolic pressures, body weight, fasting glucose, fasting insulin, triglycerides, free fatty acid and Ang II level of MS rats (P < 0.05). The MS + XST group showed notable decreases in systolic and diastolic pressures than that of the MS group. The MS group showed significant increases in the SOD activity and NO level and decrease in the MDA level after being intervened with Astragali Radix. ACE and AT1R protein expressions in renal tissues of the MS group were higher than that in the NC group, but with lower ACE2 and -Mas receptor expressions (all P < 0.05). Compared with the MS group, the MS + HQ group showed significant increase in Mas receptor expression in renal tissues, whereas the MS + XST group showed notable decrease in AT1R (all P < 0.05). In conclusion, Astragali Radix can increase the Mas receptor expressions in renal tissues, decrease ACE expression and change local Ang II, MDA, NO and SOD in kidneys, so as to protect early damages in renal tissues.
Angiotensin I
;
metabolism
;
Animals
;
Astragalus Plant
;
chemistry
;
Blood Glucose
;
metabolism
;
Blood Pressure
;
drug effects
;
Drugs, Chinese Herbal
;
administration & dosage
;
Humans
;
Kidney
;
drug effects
;
injuries
;
metabolism
;
Male
;
Malondialdehyde
;
metabolism
;
Metabolic Syndrome
;
drug therapy
;
genetics
;
metabolism
;
physiopathology
;
Peptide Fragments
;
metabolism
;
Peptidyl-Dipeptidase A
;
genetics
;
metabolism
;
Proto-Oncogene Proteins
;
genetics
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, G-Protein-Coupled
;
genetics
;
metabolism
;
Signal Transduction
;
drug effects